Molecular mechanisms of pancreatic fibrogenesis

胰腺纤维化的分子机制

基本信息

  • 批准号:
    7232626
  • 负责人:
  • 金额:
    $ 24.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Extensive experimental work over the past four decades has led to a better understanding of acute and chronic pancreatitis at the morphological and biochemical level. However, these advances have not led to effective preventive and therapeutic strategies. The broad goal of this work is to better understand the pathophysiology of chronic pancreatitis at the molecular level in order to guide future preventive and therapeutic strategies. This goal will be accomplished by focusing on key extracellular events that lead to activation of the pancreatic stellate cell, the key mediator of pancreatic fibrogenesis. The aims of this proposal represent logical extensions of the preliminary work undertaken by the principal investigator to develop a mouse model that recapitulates the morphological changes of chronic pancreatitis, develop the necessary tools to measure meaningful endpoints of pancreatic fibrogenesis, and seek novel genes expressed in the pancreas during repetitive injury. The specific aims are to establish the role of angiotensin II and its receptors in the activation of pancreatic stellate cells and development of chronic pancreatitis and to establish the functional significance of thrombospondin-1 and thrombospondin-2 in the activation of pancreatic stellate cells during repetitive injury. The first aim will be accomplished by using mice with genetic deletions of angiotensinogen and angiotensin II receptors as well as highly specific receptor antagonists in mice and cultured pancreatic stellate cells. The second aim will be accomplished by using thrombospondin knockout mice to establish the role of thrombospondin-1 and thrombospondin-2 in pancreatic stellate cell activation. Accomplishing these aims will fill significant gaps in the understanding of chronic pancreatitis and this new knowledge may help identify effective treatment approaches to this disease.
描述(由申请人提供):过去四十年的大量实验工作使我们在形态学和生化水平上更好地了解了急性和慢性胰腺炎。然而,这些进展并没有导致有效的预防和治疗策略。这项工作的广泛目标是在分子水平上更好地了解慢性胰腺炎的病理生理学,以指导未来的预防和治疗策略。这一目标将通过关注导致胰腺星状细胞激活的关键细胞外事件来实现,胰腺星状细胞是胰腺纤维化的关键介质。该提案的目的是主要研究者开展的初步工作的逻辑延伸,以开发一种小鼠模型,该模型概括了慢性胰腺炎的形态学变化,开发必要的工具来测量胰腺纤维化的有意义的终点,并寻求在重复损伤期间胰腺中表达的新基因。具体目的是确定血管紧张素II及其受体在胰腺星状细胞活化和慢性胰腺炎发展中的作用,并确定血小板反应蛋白-1和血小板反应蛋白-2在重复性损伤期间胰腺星状细胞活化中的功能意义。第一个目标将通过使用血管紧张素原和血管紧张素II受体基因缺失的小鼠以及小鼠和培养的胰腺星状细胞中的高度特异性受体拮抗剂来实现。第二个目标将通过使用血小板反应蛋白敲除小鼠来确定血小板反应蛋白-1和血小板反应蛋白-2在胰腺星状细胞活化中的作用来实现。实现这些目标将填补对慢性胰腺炎理解的重大空白,这些新知识可能有助于确定这种疾病的有效治疗方法。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.
通过 AT1a 和 AT1b 受体的血管紧张素 II 信号传导在小鼠中雨蛙素诱导的慢性胰腺炎的发展中没有作用。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRENT A NEUSCHWANDER-TETRI其他文献

BRENT A NEUSCHWANDER-TETRI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRENT A NEUSCHWANDER-TETRI', 18)}}的其他基金

The Saint Louis University Component of the NASH Clinical Research Network
圣路易斯大学 NASH 临床研究网络的组成部分
  • 批准号:
    8012130
  • 财政年份:
    2010
  • 资助金额:
    $ 24.53万
  • 项目类别:
Molecular mechanisms of pancreatic fibrogenesis
胰腺纤维化的分子机制
  • 批准号:
    6781314
  • 财政年份:
    2004
  • 资助金额:
    $ 24.53万
  • 项目类别:
Molecular mechanisms of pancreatic fibrogenesis
胰腺纤维化的分子机制
  • 批准号:
    6890890
  • 财政年份:
    2004
  • 资助金额:
    $ 24.53万
  • 项目类别:
Molecular mechanisms of pancreatic fibrogenesis
胰腺纤维化的分子机制
  • 批准号:
    7080388
  • 财政年份:
    2004
  • 资助金额:
    $ 24.53万
  • 项目类别:
The Saint Louis University Component of the NASH CRN
NASH CRN 的圣路易斯大学组成部分
  • 批准号:
    10451753
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:
Hyperinsulinemia and the pathogenesis of NASH
高胰岛素血症与 NASH 的发病机制
  • 批准号:
    7038344
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:
Hyperinsulinemia and the pathogenesis of NASH
高胰岛素血症与 NASH 的发病机制
  • 批准号:
    6863733
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:
The Saint Louis University Component of the NASH CRN
NASH CRN 的圣路易斯大学组成部分
  • 批准号:
    10018847
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:
Hyperinsulinemia and the pathogenesis of NASH
高胰岛素血症与 NASH 的发病机制
  • 批准号:
    6625910
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:
The Saint Louis University Component of the NASH CRN
NASH CRN 的圣路易斯大学组成部分
  • 批准号:
    10666704
  • 财政年份:
    2002
  • 资助金额:
    $ 24.53万
  • 项目类别:

相似海外基金

Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2022
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2021
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2020
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of the developmental mechanism of pancreatic acinar cell metaplasia in stomach
胃胰腺腺泡细胞化生发育机制的阐明
  • 批准号:
    20K16985
  • 财政年份:
    2020
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Research on carcinogenesis and cell differentiation using established human pancreatic acinar cell carcinoma cell line
利用已建立的人胰腺腺泡细胞癌细胞系进行癌发生和细胞分化的研究
  • 批准号:
    19K07518
  • 财政年份:
    2019
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of SPCA2C in acinar cell function
SPCA2C 在腺泡细胞功能中的表征
  • 批准号:
    539767-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 24.53万
  • 项目类别:
    University Undergraduate Student Research Awards
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2019
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Discovery Grants Program - Individual
The study to detect early-stage pancreatic cancer based on the data from molecular biology about the atrophic acinar cell surrounding carcinoma in situ.
该研究基于原位癌周围萎缩性腺泡细胞的分子生物学数据来检测早期胰腺癌。
  • 批准号:
    18K07897
  • 财政年份:
    2018
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of acinar cell function
腺泡细胞功能的调节
  • 批准号:
    RGPIN-2018-06444
  • 财政年份:
    2018
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Discovery Grants Program - Individual
Investigation of the role of BRG1 in acinar cell-derived pancreatic tumorigenesis
BRG1 在腺泡细胞源性胰腺肿瘤发生中的作用研究
  • 批准号:
    17H06805
  • 财政年份:
    2017
  • 资助金额:
    $ 24.53万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了